HCL Technologies Ltd. closed 21.93% short of its 52-week high of 2,011.00 rupees, which the company reached on January 13th.

HCL Technologies Ltd. 532281 shares inched up 0.64% to 1,579.10 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index 1 ...

On stocks to buy on Wednesday, Sagar Doshi of Nuvama recommended three stocks - Divis Laboratories Ltd, HCL Technologies Ltd, and Marico Ltd. A 6 month consolidation is breaking out on charts of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Google’s Gemini can now edit both AI-generated and personal images using text prompts The editing tools allow for precision changes using AI Gemini also now supports uploading up to 10 images or ...

Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”) one of the largest shareholders of Dynavax Technologies ... released an investor presentation titled “The ...

SHENZHEN, China - MicroAlgo Inc. (NASDAQ:MLGO), a technology firm specializing in encryption and algorithm development with a market capitalization of $55.18 million and annual revenue of $74.19 ...

IBM unveils powerful new AI and hybrid cloud tools at THINK 2025, boosting enterprise productivity with watsonx, LinuxONE 5, ...

The first images for the Asus Xbox handheld have been leaked Asus is developing two versions of the ROG Ally 2 that will come in white and black The black Xbox edition will sport a dedicated Xbox ...

The company itself even posted a marketing image of what looked like a new Xbox ... Commission is the US body that certifies the wireless tech inside electronics for use in the United States.

KPIT Technologies share price surged as much as 1.4 per cent in Tuesday's trading session after the company announced 100 per cent acquisition of Caresoft's Global Engineering Solutions.

Anti-Aβ antibodies (Aβ-Abs) that bind specific Aβ variants are essential research tools. Furthermore, the monoclonal Aβ-Abs Aducanumab, Lecanemab, and Donanemab have recently gained approval as the ...